SUSTAINED-RELEASE NIACIN OTC USE POSES "POTENTIALLY SERIOUS" PUBLIC HEALTH PROBLEM
This article was originally published in The Tan Sheet
Executive Summary
SUSTAINED-RELEASE NIACIN OTC USE POSES "POTENTIALLY SERIOUS" PUBLIC HEALTH PROBLEM due to liver side effects, researchers concluded from a study published in the March 2 issue of the Journal of the American Medical Association. In a randomized, double-blind parallel comparison of immediate-release and sustained-release niacin, James McKenney, PharmD, Virginia Commonwealth University, et al., found that more than half of the patients receiving a sustained-release form of niacin developed hepatotoxic reactions.